Study Summary
This trial found that a device that emits plasma can help improve skin conditions.
- Actinic Keratosis
- Bowen's Disease
- Molluscum Contagiosum
- Plantar Wart
- Athlete's Foot
- Warts
- Acne/Rosacea
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 1-12 months
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Non-thermal atmospheric plasma treatment
1 of 2
Indirect non-thermal atmospheric plasma treatment
1 of 2
Experimental Treatment
100 Total Participants · 2 Treatment Groups
Primary Treatment: Non-thermal, atmospheric plasma to treat skin lesions and acne · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age Any Age · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:- Malik, Shilpa, Melissa Gill, Gregory Fridman, Alexander Fridman, and Peter C. Friedman. 2022. “Cold Atmospheric Plasma Reduces Demodex Count on the Face Comparably to Topical Ivermectin, as Measured by Reflectance Confocal Microscopy”. Experimental Dermatology. Wiley. doi:10.1111/exd.14584.
- Malik S, Gill M, Fridman G, Fridman A, Friedman PC. Cold atmospheric plasma reduces demodex count on the face comparably to topical ivermectin, as measured by reflectance confocal microscopy. Exp Dermatol. 2022 Sep;31(9):1352-1354. doi: 10.1111/exd.14584. Epub 2022 May 11. No abstract available.
- 2016. "Using a Cold Atmospheric Plasma Device to Treat Skin Disorders". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02759900.
Frequently Asked Questions
Is enrollment ongoing for this experiment?
"The study, initially advertised on January 1st 2016 and last modified on April 10th 2022 is still in need of participants. The details can be foundon clinicaltrials.gov." - Anonymous Online Contributor
What is the aggregate count of participants enrolled in this trial?
"Indeed, the information listed on clinicaltrials.gov affirms that this medical study is currently enrolling participants. Initially posted on January 1st 2016 and most recently updated on April 10th 2022, the trial calls for 100 volunteers to take part at a single site." - Anonymous Online Contributor